Literature DB >> 8020601

Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.

G De Petro1, A Copeta, S Barlati.   

Abstract

In this study we have verified the mitogenic effect of urokinase-type (u-PA) and tissue-type plasminogen activators (t-PA) on human normal fibroblasts. We report that both PAs can induce DNA replication and cell division in serum-deprived cultured human skin fibroblasts. The activity of u-PA and t-PA is, respectively, three- and twofold more potent than that exerted by epidermal growth factor (EGF) with an activity slightly lower (50-60%) than that induced by basic fibroblast growth factor (bFGF). The u-PA and t-PA, but not plasmin, induced DNA synthesis, which could be neutralized by anti-u-PA and anti-t-PA antibodies, respectively, but was insensitive to aprotinin treatment. The addition of anti-u-PA-receptor (u-PAR) monoclonal antibodies to the assays selectively suppressed the mitogenic effect exerted by u-PA, but not that of t-PA, and the amino-terminal fragment of u-PA, containing the EGF-like domain and the kringle module, did not elicit any mitogenic activity. Anti-bFGF antibodies completely suppressed the mitogenic activity of bFGF, but did not have any effect on that of u-PA and t-PA; the activity of both PAs was inhibited by anti-fibronectin IgG concentrations ineffective on bFGF. These results indicate that PAs may be considered growth factors of human fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020601     DOI: 10.1006/excr.1994.1200

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.

Authors:  V Stepanova; S Mukhina; E Köhler; T J Resink; P Erne; V A Tkachuk
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.

Authors:  S Sheng; B Truong; D Fredrickson; R Wu; A B Pardee; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

3.  Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.

Authors:  D A Fishman; A Kearns; S Larsh; J J Enghild; M S Stack
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

4.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.

Authors:  Roderik M Kortlever; Paul J Higgins; René Bernards
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

5.  Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.

Authors:  Alessandro Salvi; Italia Bongarzone; Francesca Miccichè; Bruna Arici; Sergio Barlati; Giuseppina De Petro
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

6.  Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

Authors:  Elena Ortiz-Zapater; Sandra Peiró; Oriol Roda; Josep M Corominas; Susana Aguilar; Coral Ampurdanés; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

7.  Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

8.  Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.

Authors:  Thomas H Sisson; Mai-Huong Nguyen; Bi Yu; Margaret L Novak; Richard H Simon; Timothy J Koh
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

9.  Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.

Authors:  P Carmeliet; L Moons; M Dewerchin; S Rosenberg; J M Herbert; F Lupu; D Collen
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

10.  Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.

Authors:  A S Levenson; H C Kwaan; K M Svoboda; I M Weiss; S Sakurai; V C Jordan
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.